US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Atea Pharmaceuticals, Inc.

5.51

+0.08001.47%

Volume:100.10K

Turnover:545.71K

Market Cap:441.93M

PE:-2.63

High:5.53

Open:5.39

Low:5.25

Close:5.43

52wk High:6.45

52wk Low:2.78

Shares:80.20M

Float Shares:60.05M

Volume Ratio:0.44

T/O Rate:0.17%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.0959

EPS(LYR):-1.9430

ROE:-58.14%

ROA:-36.72%

PB:2.16

PE(LYR):-2.84

Loading ...

Overview Company News Filings

Atea Pharmaceuticals Initiates First-in-human Phase 1 Clinical Trial of At-587 for the Treatment of Hepatitis E Virus

THOMSON REUTERS

Atea Completes Enrollment in Phase 3 C-forward Trial of Bemnifosbuvir-ruzasvir Hepatitis C Regimen

Atea Pharmaceuticals - C-beyond Phase 3 Topline Results Expected Mid-year 2026

THOMSON REUTERS

Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-forward Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus

THOMSON REUTERS

Akebia Therapeutics And 2 Other Promising Penny Stocks To Watch

Simply Wall St.

Atea Shareholders Back Directors, Auditors and Executive Pay

Atea Pharmaceuticals holds annual shareholder meeting

Atea says Phase 1 study shows omeprazole does not affect bemnifosbuvir-ruzasvir HCV regimen exposure

Atea Pharmaceuticals Inc - Phase 1 Study Shows Bem/Rzr Safe and Well-Tolerated With or Without Omeprazole

THOMSON REUTERS

Atea Pharmaceuticals Inc - Omeprazole at 20 Mg Does Not Affect Bem/Rzr Plasma Exposure; 40 Mg Slightly Reduces Exposure

THOMSON REUTERS

Atea Pharmaceuticals Presents New Drug-Drug Interaction Results Supporting Potential Best-in-Class Profile of the Regimen of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at Easl Congress 2026

THOMSON REUTERS

Atea director Polly Murphy buys 6,100 shares worth $25,446.15

Atea Pharmaceuticals (AVIR) Receives a Hold from Morgan Stanley

Atea Pharmaceuticals Sets Up Catalyst-Rich 2026 Earnings Call

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ibio (IBIO), MaxCyte (MXCT) and Atea Pharmaceuticals (AVIR)

Atea presents new HCV trial data on bemnifosbuvir-ruzasvir at EASL 2026

Atea Pharmaceuticals to Present Three Abstracts at EASL 2026 Congress Highlighting Progress Across Viral Hepatitis Pipeline

BRIEF-Atea Pharmaceuticals Reports First Quarter 2026 Financial Results

Atea Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Atea Pharmaceuticals Q1 net loss widens on higher R&D spending

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/AVIR/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AVIR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVIR\",,,,,undefined,":{"symbol":"AVIR","market":"US","secType":"STK","nameCN":"Atea Pharmaceuticals, Inc.","latestPrice":5.51,"timestamp":1787601600000,"preClose":5.43,"halted":0,"volume":100100,"delay":0,"changeRate":0.014732965009208118,"floatShares":60052299,"shares":80204699,"eps":-2.095917,"marketStatus":"Pre-Mkt","change":0.08,"latestTime":"08-25 04:47:20 EDT","open":5.385,"high":5.53,"low":5.25,"amount":545712.80764,"amplitude":0.051565,"askPrice":6.23,"askSize":100,"bidPrice":3.72,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.095917,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787664600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1604030400000,"exchange":"NASDAQ","adjPreClose":5.51,"postHourTrading":{"tag":"盘后","latestPrice":5.41,"preClose":5.51,"latestTime":"19:30 EDT","volume":3615,"amount":19955.81,"timestamp":1787614206711,"change":-0.1,"changeRate":-0.018149,"amplitude":0.034483},"volumeRatio":0.4426946972945993,"impliedVol":1.3216,"impliedVolPercentile":0.496},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVIR\",,,,,undefined,":{"symbol":"AVIR","floatShares":60052299,"roa":"-36.72%","roe":"-58.14%","lyrEps":-1.943043,"volumeRatio":0.4426946972945993,"shares":80204699,"dividePrice":0,"high":5.53,"amplitude":0.051565,"preClose":5.43,"low":5.25,"week52Low":2.78,"pbRate":"2.16","psRate":"2.30","week52High":6.45,"institutionHeld":0.4276,"latestPrice":5.51,"eps":-2.095917,"divideRate":0,"volume":100100,"delay":0,"ttmEps":-2.095917,"open":5.385,"prevYearClose":3.57,"prevWeekClose":5.43,"prevMonthClose":4.7,"prevQuarterClose":4.65,"fiveDayClose":5.22,"twentyDayClose":4.82,"sixtyDayClose":4.73},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVIR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"AVIR","fiscalQuarterEnding":"2026/06","expectedEps":-0.56,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.41},{"market":"US","date":"2026-05-12","symbol":"AVIR","fiscalQuarterEnding":"2026/03","expectedEps":-0.6,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.57},{"market":"US","date":"2026-03-05","symbol":"AVIR","fiscalQuarterEnding":"2025/12","expectedEps":-0.49,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":-0.57},{"market":"US","date":"2025-11-12","symbol":"AVIR","fiscalQuarterEnding":"2025/09","expectedEps":-0.46,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.53},{"market":"US","date":"2025-08-07","symbol":"AVIR","fiscalQuarterEnding":"2025/06","expectedEps":-0.46,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.44}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVIR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AVIR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.3333,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":3,"updateTime":1764388800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AVIR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AVIR","date":"2026-08-21","current":-2.628921,"percent":0.117304,"low":-3.860976,"twenty":-2.394551,"median":-1.739445,"eighty":12.32734,"high":104.603061,"avg":6.546025,"sd":17.519013,"marketCap":429897186},"quantilePoints":[{"date":"2021-08-27","current":73.543529,"twenty":-187.46133,"median":-129.708455,"eighty":79.811155,"marketCap":2595056974},{"date":"2021-09-03","current":67.819567,"twenty":-186.988253,"median":-125.64118,"eighty":79.769358,"marketCap":2393081248},{"date":"2021-09-10","current":67.092343,"twenty":-186.819178,"median":-123.385381,"eighty":79.6579,"marketCap":2367420398},{"date":"2021-09-17","current":61.532592,"twenty":-186.754529,"median":-116.674948,"eighty":79.170269,"marketCap":2171239057},{"date":"2021-09-24","current":75.396779,"twenty":-185.83684,"median":-107.184641,"eighty":78.431857,"marketCap":2660450755},{"date":"2021-10-01","current":98.550675,"twenty":-184.365164,"median":-99.847598,"eighty":79.353564,"marketCap":3477459123},{"date":"2021-10-08","current":93.976197,"twenty":-183.486247,"median":-95.199284,"eighty":79.950478,"marketCap":3316044096},{"date":"2021-10-15","current":92.146406,"twenty":-182.808676,"median":-92.009265,"eighty":81.232249,"marketCap":3251478085},{"date":"2021-10-22","current":29.86313,"twenty":-182.369073,"median":-82.507565,"eighty":81.232249,"marketCap":1053750408},{"date":"2021-10-29","current":27.306114,"twenty":-181.597122,"median":-78.679542,"eighty":81.099892,"marketCap":963523546},{"date":"2021-11-05","current":25.359029,"twenty":-180.96794,"median":-70.955139,"eighty":80.856077,"marketCap":894818688},{"date":"2021-11-12","current":38.198876,"twenty":-179.102829,"median":-70.055098,"eighty":80.32665,"marketCap":944047012},{"date":"2021-11-19","current":27.2705,"twenty":-177.005044,"median":-64.575101,"eighty":79.950478,"marketCap":673963140},{"date":"2021-11-26","current":27.371377,"twenty":-176.330583,"median":25.218276,"eighty":79.83902,"marketCap":676456222},{"date":"2021-12-03","current":27.102371,"twenty":-176.111839,"median":25.704021,"eighty":79.783291,"marketCap":669808003},{"date":"2021-12-10","current":26.799739,"twenty":-175.627494,"median":26.093598,"eighty":79.69273,"marketCap":662328758},{"date":"2021-12-17","current":28.750034,"twenty":-174.603768,"median":26.564359,"eighty":79.431789,"marketCap":710528341},{"date":"2021-12-23","current":30.633077,"twenty":-173.693594,"median":26.850178,"eighty":79.136017,"marketCap":757065870},{"date":"2021-12-31","current":30.061439,"twenty":-173.535454,"median":27.03512,"eighty":78.738368,"marketCap":742938406},{"date":"2022-01-07","current":25.690089,"twenty":-172.807662,"median":27.068745,"eighty":77.999956,"marketCap":634904857},{"date":"2022-01-14","current":24.546813,"twenty":-172.137986,"median":26.900617,"eighty":77.393902,"marketCap":606649929},{"date":"2022-01-21","current":21.654996,"twenty":-171.736956,"median":26.766114,"eighty":76.975933,"marketCap":535181581},{"date":"2022-01-28","current":22.865524,"twenty":-171.71417,"median":26.328978,"eighty":76.662456,"marketCap":565098564},{"date":"2022-02-04","current":23.000027,"twenty":-171.312553,"median":26.093598,"eighty":76.488302,"marketCap":568422673},{"date":"2022-02-11","current":22.66377,"twenty":-168.09122,"median":25.807779,"eighty":75.396779,"marketCap":560112400},{"date":"2022-02-18","current":19.906456,"twenty":-167.924698,"median":25.690089,"eighty":75.396779,"marketCap":491968161},{"date":"2022-02-25","current":21.419616,"twenty":-166.976098,"median":25.359029,"eighty":75.378012,"marketCap":529364390},{"date":"2022-03-04","current":3.948735,"twenty":-166.48873,"median":24.788709,"eighty":75.073047,"marketCap":478547148},{"date":"2022-03-11","current":3.976204,"twenty":-166.354602,"median":24.479561,"eighty":74.992061,"marketCap":481876171},{"date":"2022-03-18","current":4.862094,"twenty":-165.393701,"median":23.807046,"eighty":74.851258,"marketCap":589237184},{"date":"2022-03-25","current":4.745349,"twenty":-163.949973,"median":23.269033,"eighty":74.398458,"marketCap":575088833},{"date":"2022-04-01","current":4.875829,"twenty":-161.638082,"median":23.117718,"eighty":74.106492,"marketCap":590901696},{"date":"2022-04-08","current":4.573665,"twenty":-161.010797,"median":23.000027,"eighty":73.646748,"marketCap":554282436},{"date":"2022-04-14","current":4.525593,"twenty":-160.926372,"median":22.865524,"eighty":73.205722,"marketCap":548456644},{"date":"2022-04-22","current":4.044878,"twenty":-160.06327,"median":22.058506,"eighty":72.410188,"marketCap":490198730},{"date":"2022-04-29","current":4.032693,"twenty":-159.488323,"median":21.654996,"eighty":71.812079,"marketCap":488722059},{"date":"2022-05-06","current":3.792243,"twenty":-159.382162,"median":21.503681,"eighty":71.654826,"marketCap":459581902},{"date":"2022-05-13","current":12.540245,"twenty":-159.155821,"median":20.915229,"eighty":71.605033,"marketCap":606947838},{"date":"2022-05-20","current":12.884284,"twenty":-158.986223,"median":20.141837,"eighty":71.560583,"marketCap":623599356},{"date":"2022-05-27","current":14.071221,"twenty":-158.913003,"median":19.502947,"eighty":71.524315,"marketCap":681047094},{"date":"2022-06-03","current":13.417546,"twenty":-158.867831,"median":13.555162,"eighty":71.479642,"marketCap":649409209},{"date":"2022-06-10","current":13.27993,"twenty":-158.508321,"median":13.709979,"eighty":71.312455,"marketCap":642748602},{"date":"2022-06-17","current":11.181288,"twenty":-157.53242,"median":13.53796,"eighty":70.650671,"marketCap":541174341},{"date":"2022-06-24","current":12.265013,"twenty":-156.71581,"median":13.27993,"eighty":69.928889,"marketCap":593626623},{"date":"2022-07-01","current":12.557447,"twenty":-156.024233,"median":12.93589,"eighty":69.874563,"marketCap":607780414},{"date":"2022-07-08","current":13.606767,"twenty":-154.624782,"median":12.93589,"eighty":69.837029,"marketCap":658567544},{"date":"2022-07-15","current":13.933605,"twenty":-154.533639,"median":13.27993,"eighty":69.719735,"marketCap":674386487},{"date":"2022-07-22","current":13.761585,"twenty":-153.804491,"median":13.443349,"eighty":69.602441,"marketCap":666060728},{"date":"2022-07-29","current":14.105625,"twenty":-152.114706,"median":13.555162,"eighty":69.578982,"marketCap":682712246},{"date":"2022-08-05","current":15.120542,"twenty":-149.194038,"median":13.675575,"eighty":69.156722,"marketCap":731834224},{"date":"2022-08-12","current":45.098857,"twenty":-148.839779,"median":13.813191,"eighty":68.570251,"marketCap":700204851},{"date":"2022-08-19","current":44.187227,"twenty":-148.362663,"median":13.881999,"eighty":68.523333,"marketCap":686050888},{"date":"2022-08-26","current":41.988591,"twenty":-146.01173,"median":13.933605,"eighty":68.030697,"marketCap":651914861},{"date":"2022-09-02","current":39.95083,"twenty":-143.642002,"median":14.019615,"eighty":67.989602,"marketCap":620276592},{"date":"2022-09-09","current":42.256717,"twenty":-141.199359,"median":14.06262,"eighty":67.909876,"marketCap":656077791},{"date":"2022-09-16","current":35.98256,"twenty":-137.781481,"median":14.088423,"eighty":67.833642,"marketCap":558665226},{"date":"2022-09-23","current":31.10266,"twenty":-136.751561,"median":14.217438,"eighty":67.500527,"marketCap":482899897},{"date":"2022-09-30","current":30.512782,"twenty":-136.614846,"median":14.535674,"eighty":67.27063,"marketCap":473741451},{"date":"2022-10-07","current":28.957649,"twenty":-135.731607,"median":14.862512,"eighty":67.176794,"marketCap":449596456},{"date":"2022-10-14","current":28.15327,"twenty":-135.514215,"median":19.872831,"eighty":67.106418,"marketCap":437107665},{"date":"2022-10-21","current":28.528647,"twenty":-134.907259,"median":20.562159,"eighty":66.974213,"marketCap":442935767},{"date":"2022-10-28","current":31.638913,"twenty":-134.153974,"median":21.38599,"eighty":66.781304,"marketCap":491225757},{"date":"2022-11-04","current":32.389666,"twenty":-133.711929,"median":21.604558,"eighty":65.670736,"marketCap":502881962},{"date":"2022-11-11","current":12.077105,"twenty":-132.636436,"median":21.38599,"eighty":65.403305,"marketCap":430597093},{"date":"2022-11-18","current":10.909106,"twenty":-131.930075,"median":20.562159,"eighty":65.103031,"marketCap":388953274},{"date":"2022-11-25","current":10.955826,"twenty":-129.286916,"median":19.889643,"eighty":64.999812,"marketCap":390619026},{"date":"2022-12-02","current":11.212786,"twenty":-126.766801,"median":15.120542,"eighty":64.938819,"marketCap":399780667},{"date":"2022-12-09","current":10.255027,"twenty":-125.869038,"median":14.552876,"eighty":64.150601,"marketCap":365632735},{"date":"2022-12-16","current":10.768946,"twenty":-124.451759,"median":14.260443,"eighty":62.377111,"marketCap":383956015},{"date":"2022-12-23","current":10.722226,"twenty":-123.494753,"median":14.097024,"eighty":61.180709,"marketCap":382290263},{"date":"2022-12-30","current":11.236146,"twenty":-122.738263,"median":14.071221,"eighty":55.100568,"marketCap":400613543},{"date":"2023-01-06","current":10.979186,"twenty":-121.156924,"median":14.045418,"eighty":46.278613,"marketCap":391451903},{"date":"2023-01-13","current":11.516465,"twenty":-117.898548,"median":13.950807,"eighty":46.053387,"marketCap":410608060},{"date":"2023-01-20","current":11.446386,"twenty":-114.635614,"median":13.899201,"eighty":46.010486,"marketCap":408109431},{"date":"2023-01-27","current":10.745586,"twenty":-109.508798,"median":13.856196,"eighty":45.903236,"marketCap":383123139},{"date":"2023-02-03","current":10.535347,"twenty":-107.184641,"median":13.761585,"eighty":45.474234,"marketCap":375627251},{"date":"2023-02-10","current":9.834548,"twenty":-103.060402,"median":13.659535,"eighty":45.098857,"marketCap":350640960},{"date":"2023-02-17","current":9.927987,"twenty":-100.850175,"median":13.555162,"eighty":44.937981,"marketCap":353972465},{"date":"2023-02-24","current":8.573109,"twenty":-99.246051,"median":13.469152,"eighty":44.466079,"marketCap":305665635},{"date":"2023-03-03","current":-2.538161,"twenty":-95.964888,"median":13.331536,"eighty":44.219402,"marketCap":294195756},{"date":"2023-03-10","current":-2.401547,"twenty":-95.208398,"median":12.953092,"eighty":44.144327,"marketCap":278360857},{"date":"2023-03-17","current":-2.710728,"twenty":-95.071683,"median":12.884284,"eighty":43.9191,"marketCap":314197733},{"date":"2023-03-24","current":-2.157078,"twenty":-94.511151,"median":12.695062,"eighty":43.736775,"marketCap":250024722},{"date":"2023-03-31","current":-2.408737,"twenty":-90.587427,"median":12.600452,"eighty":43.532999,"marketCap":279194272},{"date":"2023-04-05","current":-2.415927,"twenty":-89.411678,"median":12.557447,"eighty":43.425749,"marketCap":280027688},{"date":"2023-04-14","current":-2.423117,"twenty":-86.44496,"median":12.505841,"eighty":43.221972,"marketCap":280861104},{"date":"2023-04-21","current":-2.344024,"twenty":-81.331815,"median":12.282215,"eighty":42.953846,"marketCap":271693531},{"date":"2023-04-28","current":-2.379976,"twenty":-79.258302,"median":12.230609,"eighty":42.578469,"marketCap":275860609},{"date":"2023-05-05","current":-2.396017,"twenty":-78.702328,"median":12.100465,"eighty":42.149467,"marketCap":277719925},{"date":"2023-05-12","current":-2.525658,"twenty":-78.228382,"median":11.92588,"eighty":41.83844,"marketCap":276051937},{"date":"2023-05-19","current":-2.739309,"twenty":-75.015577,"median":11.731751,"eighty":41.570314,"marketCap":299403763},{"date":"2023-05-26","current":-3.53287,"twenty":-70.863995,"median":11.512296,"eighty":41.205661,"marketCap":386139115},{"date":"2023-06-02","current":-3.113198,"twenty":-70.608794,"median":11.483414,"eighty":40.647959,"marketCap":340269458},{"date":"2023-06-09","current":-3.258176,"twenty":-70.102948,"median":11.446386,"eighty":40.186782,"marketCap":356115339},{"date":"2023-06-16","current":-3.166611,"twenty":-69.546973,"median":11.318087,"eighty":40.036631,"marketCap":346107414},{"date":"2023-06-23","current":-2.983482,"twenty":-67.833477,"median":11.259506,"eighty":39.95083,"marketCap":326091564},{"date":"2023-06-30","current":-2.861395,"twenty":-65.226776,"median":11.224466,"eighty":39.95083,"marketCap":312747663},{"date":"2023-07-07","current":-2.75457,"twenty":-28.146626,"median":11.197037,"eighty":39.182114,"marketCap":301071750},{"date":"2023-07-14","current":-2.861395,"twenty":-3.801459,"median":11.166066,"eighty":38.537448,"marketCap":312747663},{"date":"2023-07-21","current":-2.807983,"twenty":-3.706843,"median":11.072626,"eighty":38.299055,"marketCap":306909707},{"date":"2023-07-28","current":-2.540919,"twenty":-3.6107,"median":11.002546,"eighty":38.198876,"marketCap":277719925},{"date":"2023-08-04","current":-2.640114,"twenty":-3.548131,"median":10.967506,"eighty":37.383889,"marketCap":288561844},{"date":"2023-08-11","current":-2.663513,"twenty":-3.496244,"median":10.955826,"eighty":36.776214,"marketCap":282723888},{"date":"2023-08-18","current":-2.67137,"twenty":-3.448936,"median":10.920786,"eighty":36.282862,"marketCap":283557881},{"date":"2023-08-25","current":-2.639942,"twenty":-3.383314,"median":10.909106,"eighty":35.775559,"marketCap":280221906},{"date":"2023-09-01","current":-2.639942,"twenty":-3.29938,"median":10.885746,"eighty":34.557553,"marketCap":280221906},{"date":"2023-09-08","current":-2.577086,"twenty":-3.262754,"median":10.803986,"eighty":33.730299,"marketCap":273549956},{"date":"2023-09-15","current":-2.577086,"twenty":-3.258176,"median":10.768946,"eighty":33.569423,"marketCap":273549956},{"date":"2023-09-21","current":-2.498516,"twenty":-3.22155,"median":10.768946,"eighty":33.151146,"marketCap":265210018},{"date":"2023-10-06","current":-2.364948,"twenty":-3.197133,"median":10.768946,"eighty":32.872294,"marketCap":251032124},{"date":"2023-10-09","current":-2.33352,"twenty":-3.191029,"median":10.768946,"eighty":32.797219,"marketCap":247696149},{"date":"2023-10-17","current":-2.357091,"twenty":-3.184924,"median":10.757266,"eighty":32.722143,"marketCap":250198131},{"date":"2023-11-01","current":-2.553515,"twenty":-3.172715,"median":10.733906,"eighty":32.571992,"marketCap":271047975},{"date":"2023-11-10","current":-1.900308,"twenty":-3.162033,"median":10.710546,"eighty":32.464742,"marketCap":249364137},{"date":"2023-11-17","current":-1.850265,"twenty":-3.149824,"median":10.675507,"eighty":32.429404,"marketCap":242797342},{"date":"2023-11-24","current":-1.812115,"twenty":-3.14372,"median":10.628787,"eighty":32.407954,"marketCap":237791212},{"date":"2023-12-01","current":-1.901132,"twenty":-3.140668,"median":10.582067,"eighty":32.303866,"marketCap":249472183},{"date":"2023-12-08","current":-1.86934,"twenty":-3.129985,"median":10.535347,"eighty":32.153715,"marketCap":245300408},{"date":"2023-12-15","current":-1.894773,"twenty":-3.117777,"median":10.42211,"eighty":31.956565,"marketCap":248637828},{"date":"2023-12-22","current":-1.996506,"twenty":-3.10099,"median":10.266707,"eighty":31.681026,"marketCap":261987510},{"date":"2023-12-29","current":-1.971073,"twenty":-3.082677,"median":10.255027,"eighty":31.638913,"marketCap":258650090},{"date":"2024-01-05","current":-1.971073,"twenty":-3.064364,"median":10.231667,"eighty":31.638913,"marketCap":258650090},{"date":"2024-01-12","current":-2.276271,"twenty":-3.047577,"median":10.184947,"eighty":31.478037,"marketCap":298699136},{"date":"2024-01-19","current":-2.269913,"twenty":-3.035369,"median":10.004174,"eighty":31.263536,"marketCap":297864781},{"date":"2024-01-26","current":-2.397079,"twenty":-3.006373,"median":9.834548,"eighty":31.085409,"marketCap":314551884},{"date":"2024-02-02","current":-2.683202,"twenty":-2.946856,"median":9.577588,"eighty":31.055333,"marketCap":352097864},{"date":"2024-02-09","current":-2.708636,"twenty":-2.891917,"median":9.390708,"eighty":30.990254,"marketCap":355435285},{"date":"2024-02-16","current":-2.676844,"twenty":-2.888865,"median":8.806709,"eighty":30.896513,"marketCap":351263509},{"date":"2024-02-23","current":-2.562395,"twenty":-2.882761,"median":6.674963,"eighty":30.855984,"marketCap":336245117},{"date":"2024-03-01","current":-2.668137,"twenty":-2.882761,"median":4.999441,"eighty":30.721892,"marketCap":362749188},{"date":"2024-03-08","current":-2.525754,"twenty":-2.873604,"median":4.937635,"eighty":30.686879,"marketCap":343391343},{"date":"2024-03-15","current":-2.38337,"twenty":-2.861395,"median":4.862094,"eighty":30.626352,"marketCap":324033498},{"date":"2024-03-22","current":-2.538135,"twenty":-2.859869,"median":4.779686,"eighty":30.582117,"marketCap":345074634},{"date":"2024-03-28","current":-2.476229,"twenty":-2.853765,"median":4.714446,"eighty":30.512782,"marketCap":336658180},{"date":"2024-04-05","current":-2.38337,"twenty":-2.838504,"median":4.601134,"eighty":30.431323,"marketCap":324033498},{"date":"2024-04-12","current":-2.38337,"twenty":-2.823244,"median":4.553063,"eighty":30.405531,"marketCap":324033498},{"date":"2024-04-19","current":-2.290512,"twenty":-2.823244,"median":4.525593,"eighty":30.351906,"marketCap":311408816},{"date":"2024-04-26","current":-2.284321,"twenty":-2.815613,"median":4.46722,"eighty":30.08378,"marketCap":310567171},{"date":"2024-05-03","current":-2.372639,"twenty":-2.815613,"median":4.353909,"eighty":30.061439,"marketCap":322574473},{"date":"2024-05-10","current":-2.434588,"twenty":-2.807983,"median":4.312705,"eighty":30.030154,"marketCap":330996783},{"date":"2024-05-17","current":-1.904126,"twenty":-2.800352,"median":4.257766,"eighty":29.976529,"marketCap":311625470},{"date":"2024-05-24","current":-1.89898,"twenty":-2.792722,"median":4.22424,"eighty":29.910048,"marketCap":310783239},{"date":"2024-05-31","current":-1.85781,"twenty":-2.783638,"median":4.207069,"eighty":29.872514,"marketCap":304045391},{"date":"2024-06-07","current":-1.955589,"twenty":-2.778242,"median":4.154756,"eighty":29.844363,"marketCap":320047780},{"date":"2024-06-14","current":-1.904126,"twenty":-2.777461,"median":4.051745,"eighty":29.76091,"marketCap":311625470},{"date":"2024-06-21","current":-1.76003,"twenty":-2.777461,"median":4.044878,"eighty":29.688214,"marketCap":288043002},{"date":"2024-06-28","current":-1.739445,"twenty":-2.777461,"median":4.032693,"eighty":29.668025,"marketCap":284674078},{"date":"2024-07-05","current":-1.687982,"twenty":-2.777461,"median":3.976204,"eighty":29.559513,"marketCap":276251768},{"date":"2024-07-12","current":-1.734299,"twenty":-2.763867,"median":3.884237,"eighty":29.461726,"marketCap":283831847},{"date":"2024-07-15","current":-1.765176,"twenty":-2.759336,"median":3.860943,"eighty":29.451001,"marketCap":288885233},{"date":"2024-08-02","current":-1.868102,"twenty":-2.754805,"median":3.826593,"eighty":29.440276,"marketCap":305729853},{"date":"2024-08-09","current":-1.678875,"twenty":-2.75457,"median":3.661713,"eighty":29.440276,"marketCap":295477000},{"date":"2024-08-16","current":-1.793998,"twenty":-2.753144,"median":-1.61172,"eighty":29.220795,"marketCap":315738280},{"date":"2024-08-23","current":-1.813185,"twenty":-2.746785,"median":-1.641665,"eighty":29.220795,"marketCap":319115160},{"date":"2024-08-30","current":-1.813185,"twenty":-2.742082,"median":-1.683428,"eighty":29.17215,"marketCap":319115160},{"date":"2024-09-06","current":-1.736437,"twenty":-2.739864,"median":-1.687982,"eighty":29.086853,"marketCap":305607640},{"date":"2024-09-13","current":-1.760421,"twenty":-2.724943,"median":-1.693128,"eighty":29.001437,"marketCap":309828740},{"date":"2024-09-20","current":-1.832372,"twenty":-2.712853,"median":-1.726843,"eighty":28.985414,"marketCap":322492040},{"date":"2024-09-27","current":-1.650094,"twenty":-2.709176,"median":-1.703421,"eighty":28.963202,"marketCap":290411680},{"date":"2024-10-04","current":-1.59733,"twenty":-2.708666,"median":-1.687982,"eighty":28.871848,"marketCap":281125260},{"date":"2024-10-11","current":-1.602127,"twenty":-2.708636,"median":-1.687982,"eighty":28.797008,"marketCap":281969480},{"date":"2024-10-18","current":-1.789201,"twenty":-2.688289,"median":-1.687982,"eighty":28.756759,"marketCap":314894060},{"date":"2024-10-25","current":-1.621314,"twenty":-2.682118,"median":-1.687982,"eighty":28.750034,"marketCap":285346360},{"date":"2024-10-31","current":-1.573346,"twenty":-2.680275,"median":-1.687982,"eighty":28.629674,"marketCap":276904160},{"date":"2024-11-08","current":-1.668975,"twenty":-2.679227,"median":-1.678875,"eighty":28.536962,"marketCap":290411680},{"date":"2024-11-15","current":-1.606684,"twenty":-2.677797,"median":-1.672543,"eighty":28.464296,"marketCap":279572725},{"date":"2024-11-22","current":-1.57756,"twenty":-2.676844,"median":-1.669129,"eighty":28.421396,"marketCap":274504941},{"date":"2024-11-29","current":-1.660079,"twenty":-2.674654,"median":-1.659884,"eighty":28.357046,"marketCap":288863661},{"date":"2024-12-06","current":-1.422231,"twenty":-2.671016,"median":-1.660079,"eighty":28.23907,"marketCap":247476762},{"date":"2024-12-13","current":-1.431939,"twenty":-2.669546,"median":-1.652631,"eighty":28.185445,"marketCap":249166024},{"date":"2024-12-20","current":-1.519312,"twenty":-2.666287,"median":-1.650094,"eighty":28.152215,"marketCap":264369374},{"date":"2024-12-27","current":-1.596976,"twenty":-2.661942,"median":-1.641665,"eighty":28.145941,"marketCap":277883464},{"date":"2025-01-03","current":-1.660079,"twenty":-2.655656,"median":-1.640501,"eighty":28.127174,"marketCap":288863661},{"date":"2025-01-10","current":-1.621246,"twenty":-2.655656,"median":-1.640501,"eighty":28.070873,"marketCap":282106617},{"date":"2025-01-17","current":-1.616392,"twenty":-2.649327,"median":-1.635704,"eighty":27.992672,"marketCap":281261986},{"date":"2025-01-24","current":-1.50475,"twenty":-2.646707,"median":-1.633539,"eighty":27.93629,"marketCap":261835482},{"date":"2025-01-31","current":-1.451355,"twenty":-2.645438,"median":-1.630955,"eighty":27.830492,"marketCap":252544546},{"date":"2025-02-07","current":-1.50475,"twenty":-2.64209,"median":-1.626106,"eighty":27.755914,"marketCap":261835482},{"date":"2025-02-14","current":-1.509604,"twenty":-2.640114,"median":-1.621314,"eighty":27.677227,"marketCap":262680113},{"date":"2025-02-21","current":-1.524166,"twenty":-2.640045,"median":-1.616517,"eighty":27.578237,"marketCap":265214005},{"date":"2025-02-28","current":-1.485334,"twenty":-2.639942,"median":-1.616392,"eighty":27.458272,"marketCap":258456960},{"date":"2025-03-07","current":-1.523743,"twenty":-2.639942,"median":-1.616392,"eighty":27.391553,"marketCap":256575537},{"date":"2025-03-14","current":-1.554218,"twenty":-2.639942,"median":-1.609231,"eighty":27.345272,"marketCap":261707047},{"date":"2025-03-21","current":-1.599931,"twenty":-2.639443,"median":-1.606923,"eighty":27.291868,"marketCap":269404313},{"date":"2025-03-28","current":-1.533902,"twenty":-2.63621,"median":-1.610089,"eighty":27.2705,"marketCap":258286040},{"date":"2025-04-04","current":-1.472952,"twenty":-2.632425,"median":-1.606923,"eighty":27.2436,"marketCap":248023019},{"date":"2025-04-11","current":-1.36629,"twenty":-2.632236,"median":-1.606804,"eighty":27.162898,"marketCap":230062731},{"date":"2025-04-17","current":-1.523743,"twenty":-2.632085,"median":-1.601978,"eighty":27.088921,"marketCap":256575537},{"date":"2025-04-25","current":-1.457715,"twenty":-2.632085,"median":-1.59733,"eighty":27.02167,"marketCap":245457263},{"date":"2025-05-02","current":-1.518664,"twenty":-2.630639,"median":-1.593374,"eighty":26.954418,"marketCap":255720285},{"date":"2025-05-09","current":-1.401844,"twenty":-2.624771,"median":-1.578143,"eighty":26.880441,"marketCap":236049494},{"date":"2025-05-16","current":-1.589032,"twenty":-2.624402,"median":-1.582705,"eighty":26.793014,"marketCap":221650840},{"date":"2025-05-23","current":-1.748548,"twenty":-2.624228,"median":-1.589772,"eighty":26.719038,"marketCap":243901503},{"date":"2025-05-30","current":-1.809901,"twenty":-2.624228,"median":-1.59733,"eighty":26.530733,"marketCap":252459451},{"date":"2025-06-06","current":-1.957147,"twenty":-2.619619,"median":-1.600881,"eighty":26.362604,"marketCap":272998525},{"date":"2025-06-13","current":-1.969418,"twenty":-2.619619,"median":-1.606684,"eighty":26.295353,"marketCap":274710114},{"date":"2025-06-20","current":-1.969418,"twenty":-2.617702,"median":-1.606923,"eighty":26.133949,"marketCap":274710114},{"date":"2025-06-27","current":-2.165746,"twenty":-2.617223,"median":-1.608506,"eighty":26.093598,"marketCap":302095546},{"date":"2025-07-03","current":-2.294586,"twenty":-2.612928,"median":-1.610813,"eighty":25.932194,"marketCap":320067236},{"date":"2025-07-11","current":-2.319127,"twenty":-2.609134,"median":-1.613573,"eighty":25.824592,"marketCap":323490415},{"date":"2025-07-18","current":-2.122799,"twenty":-2.608514,"median":-1.616392,"eighty":25.804416,"marketCap":296104983},{"date":"2025-07-25","current":-2.294586,"twenty":-2.604583,"median":-1.616392,"eighty":25.77079,"marketCap":320067236},{"date":"2025-08-01","current":-2.233234,"twenty":-2.601179,"median":-1.618882,"eighty":25.716989,"marketCap":311509289},{"date":"2025-08-08","current":-2.122799,"twenty":-2.600657,"median":-1.625326,"eighty":25.646281,"marketCap":296104983},{"date":"2025-08-15","current":-2.034555,"twenty":-2.600657,"median":-1.626101,"eighty":25.462248,"marketCap":276957859},{"date":"2025-08-22","current":-2.057874,"twenty":-2.600589,"median":-1.630907,"eighty":25.274577,"marketCap":280132162},{"date":"2025-08-29","current":-2.022896,"twenty":-2.596817,"median":-1.631164,"eighty":25.105673,"marketCap":275370708},{"date":"2025-09-05","current":-1.94128,"twenty":-2.594332,"median":-1.635595,"eighty":24.837088,"marketCap":264260651},{"date":"2025-09-12","current":-1.923791,"twenty":-2.594332,"median":-1.635809,"eighty":24.546813,"marketCap":261879924},{"date":"2025-09-19","current":-1.731412,"twenty":-2.594332,"median":-1.641083,"eighty":24.519912,"marketCap":235691932},{"date":"2025-09-26","current":-1.696434,"twenty":-2.593719,"median":-1.650094,"eighty":24.291257,"marketCap":230930479},{"date":"2025-10-03","current":-1.643967,"twenty":-2.590811,"median":-1.650232,"eighty":23.968449,"marketCap":223788299},{"date":"2025-10-10","current":-1.824687,"twenty":-2.586674,"median":-1.654891,"eighty":23.827221,"marketCap":248389140},{"date":"2025-10-17","current":-1.818857,"twenty":-2.5818,"median":-1.660079,"eighty":23.652367,"marketCap":247595565},{"date":"2025-10-24","current":-1.859665,"twenty":-2.577086,"median":-1.668975,"eighty":23.450612,"marketCap":253150594},{"date":"2025-10-31","current":-1.906302,"twenty":-2.554019,"median":-1.669282,"eighty":23.329559,"marketCap":259499198},{"date":"2025-11-07","current":-1.894643,"twenty":-2.538713,"median":-1.669282,"eighty":23.329559,"marketCap":257912047},{"date":"2025-11-14","current":-1.756213,"twenty":-2.525658,"median":-1.669282,"eighty":23.329559,"marketCap":239067995},{"date":"2025-11-21","current":-1.594153,"twenty":-2.501339,"median":-1.660079,"eighty":23.329559,"marketCap":234380388},{"date":"2025-11-28","current":-1.647292,"twenty":-2.498516,"median":-1.650371,"eighty":23.329559,"marketCap":242193067},{"date":"2025-12-05","current":-1.641978,"twenty":-2.480029,"median":-1.645298,"eighty":23.329559,"marketCap":241411799},{"date":"2025-12-12","current":-1.695116,"twenty":-2.476229,"median":-1.645298,"eighty":23.329559,"marketCap":249224479},{"date":"2025-12-19","current":-1.663233,"twenty":-2.467015,"median":-1.645298,"eighty":23.329559,"marketCap":244536871},{"date":"2025-12-26","current":-1.923612,"twenty":-2.454351,"median":-1.645298,"eighty":23.329559,"marketCap":282819001},{"date":"2026-01-02","current":-1.897042,"twenty":-2.442325,"median":-1.645298,"eighty":23.329559,"marketCap":278912661},{"date":"2026-01-09","current":-1.918298,"twenty":-2.434588,"median":-1.645298,"eighty":23.329559,"marketCap":282037733},{"date":"2026-01-16","current":-1.827962,"twenty":-2.414644,"median":-1.645298,"eighty":23.329559,"marketCap":268756178},{"date":"2026-01-23","current":-1.939553,"twenty":-2.408949,"median":-1.645298,"eighty":23.329559,"marketCap":285162805},{"date":"2026-01-30","current":-2.077713,"twenty":-2.397973,"median":-1.645298,"eighty":23.329559,"marketCap":305475772},{"date":"2026-02-06","current":-2.136165,"twenty":-2.385456,"median":-1.645298,"eighty":23.329559,"marketCap":314069719},{"date":"2026-02-13","current":-2.300895,"twenty":-2.380113,"median":-1.645298,"eighty":23.329559,"marketCap":338289026},{"date":"2026-02-20","current":-2.518762,"twenty":-2.379976,"median":-1.645298,"eighty":23.329559,"marketCap":370321013},{"date":"2026-02-27","current":-2.486879,"twenty":-2.379976,"median":-1.645298,"eighty":23.329559,"marketCap":365633405},{"date":"2026-03-06","current":-2.666654,"twenty":-2.379976,"median":-1.645298,"eighty":23.329559,"marketCap":422262039},{"date":"2026-03-13","current":-3.069168,"twenty":-2.379976,"median":-1.645298,"eighty":23.329559,"marketCap":485999706},{"date":"2026-03-20","current":-3.018854,"twenty":-2.379976,"median":-1.645298,"eighty":23.329559,"marketCap":478032498},{"date":"2026-03-27","current":-2.681749,"twenty":-2.379976,"median":-1.645298,"eighty":23.329559,"marketCap":424652202},{"date":"2026-04-02","current":-2.842754,"twenty":-2.379976,"median":-1.645298,"eighty":23.329559,"marketCap":450147268},{"date":"2026-04-10","current":-2.938351,"twenty":-2.379976,"median":-1.645298,"eighty":23.329559,"marketCap":465284964},{"date":"2026-04-17","current":-2.867911,"twenty":-2.379976,"median":-1.645298,"eighty":23.329559,"marketCap":454130873},{"date":"2026-04-24","current":-2.777346,"twenty":-2.379976,"median":-1.645298,"eighty":23.329559,"marketCap":439789898},{"date":"2026-05-01","current":-2.772314,"twenty":-2.379976,"median":-1.645298,"eighty":23.329559,"marketCap":438993177},{"date":"2026-05-08","current":-2.799829,"twenty":-2.379976,"median":-1.645298,"eighty":23.329559,"marketCap":443350128},{"date":"2026-05-15","current":-2.01582,"twenty":-2.379976,"median":-1.647292,"eighty":23.14798,"marketCap":341715712},{"date":"2026-05-22","current":-2.001657,"twenty":-2.379976,"median":-1.654891,"eighty":22.865524,"marketCap":339314899},{"date":"2026-05-29","current":-2.232981,"twenty":-2.379976,"median":-1.661656,"eighty":21.749148,"marketCap":378528178},{"date":"2026-06-05","current":-2.086633,"twenty":-2.379976,"median":-1.669282,"eighty":21.392715,"marketCap":353719777},{"date":"2026-06-12","current":-2.058308,"twenty":-2.379976,"median":-1.673861,"eighty":19.879556,"marketCap":348918151},{"date":"2026-06-18","current":-2.044145,"twenty":-2.379976,"median":-1.678945,"eighty":14.576959,"marketCap":346517338},{"date":"2026-06-26","current":-2.053587,"twenty":-2.379976,"median":-1.687982,"eighty":14.095304,"marketCap":348117880},{"date":"2026-07-02","current":-2.256585,"twenty":-2.379976,"median":-1.689503,"eighty":14.043698,"marketCap":382529533},{"date":"2026-07-10","current":-2.317957,"twenty":-2.379976,"median":-1.691866,"eighty":13.899201,"marketCap":392933056},{"date":"2026-07-17","current":-2.225899,"twenty":-2.379976,"median":-1.696434,"eighty":13.751264,"marketCap":377327771},{"date":"2026-07-24","current":-2.242422,"twenty":-2.379976,"median":-1.702561,"eighty":13.544841,"marketCap":380128720},{"date":"2026-07-31","current":-2.237702,"twenty":-2.379976,"median":-1.708093,"eighty":13.166397,"marketCap":379328449},{"date":"2026-08-07","current":-2.355724,"twenty":-2.379976,"median":-1.724007,"eighty":12.870522,"marketCap":399335224},{"date":"2026-08-14","current":-2.460163,"twenty":-2.38337,"median":-1.731412,"eighty":12.567768,"marketCap":406637823},{"date":"2026-08-21","current":-2.600882,"twenty":-2.394551,"median":-1.739445,"eighty":12.32734,"marketCap":429897186}],"updateTime":1787642993373},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVIR\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651177972","title":"Atea Pharmaceuticals Initiates First-in-human Phase 1 Clinical Trial of At-587 for the Treatment of Hepatitis E Virus","url":"https://stock-news.laohu8.com/highlight/detail?id=2651177972","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651177972?lang=en_us&edition=fundamental","pubTime":"2026-07-14 19:00","pubTimestamp":1784026802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nTUA33NSKR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVIR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646874767","title":"Atea Completes Enrollment in Phase 3 C-forward Trial of Bemnifosbuvir-ruzasvir Hepatitis C Regimen","url":"https://stock-news.laohu8.com/highlight/detail?id=2646874767","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646874767?lang=en_us&edition=fundamental","pubTime":"2026-06-25 19:01","pubTimestamp":1782385300,"startTime":"0","endTime":"0","summary":"Atea completes enrollment in Phase 3 C-FORWARD trial of bemnifosbuvir-ruzasvir hepatitis C regimenAtea Pharmaceuticals completed enrollment in its Phase 3 C-FORWARD trial testing bemnifosbuvir-ruzasvi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nNDL5xjQKQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4112","BK4585","SG9999014039.USD","SG9999014005.SGD","LU2095319765.USD","AVIR","BK4588","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","NDAQ","LU2210150020.SGD","LU2210149790.SGD","LU0314104364.USD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","SG9999014013.SGD","BK4007","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646874707","title":"Atea Pharmaceuticals - C-beyond Phase 3 Topline Results Expected Mid-year 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2646874707","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646874707?lang=en_us&edition=fundamental","pubTime":"2026-06-25 19:00","pubTimestamp":1782385201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nTUA6VZ75T:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AVIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646747248","title":"Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-forward Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus","url":"https://stock-news.laohu8.com/highlight/detail?id=2646747248","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646747248?lang=en_us&edition=fundamental","pubTime":"2026-06-25 19:00","pubTimestamp":1782385201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nTUA6VZ75T:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVIR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645789712","title":"Akebia Therapeutics And 2 Other Promising Penny Stocks To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2645789712","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645789712?lang=en_us&edition=fundamental","pubTime":"2026-06-24 19:05","pubTimestamp":1782299124,"startTime":"0","endTime":"0","summary":"Over the last 7 days, the U.S. market has dropped 2.3%, but it is up 21% over the past year with earnings forecasted to grow by 19% annually. In light of these conditions, identifying stocks with strong fundamentals and growth potential can be key to navigating market fluctuations. Penny stocks, though an older term, still represent a viable investment area; they often involve smaller or newer companies that offer unique growth opportunities at lower price points.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-avir/atea-pharmaceuticals/news/akebia-therapeutics-and-2-other-promising-penny-stocks-to-wa","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-avir/atea-pharmaceuticals/news/akebia-therapeutics-and-2-other-promising-penny-stocks-to-wa","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AVIR","BK4139","AKBA","SFIX","BK4094","BK4007","BK4551","BK4122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645003228","title":"Atea Shareholders Back Directors, Auditors and Executive Pay","url":"https://stock-news.laohu8.com/highlight/detail?id=2645003228","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645003228?lang=en_us&edition=fundamental","pubTime":"2026-06-23 06:24","pubTimestamp":1782167061,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals ( ($AVIR) ) has shared an announcement. On June 18, 2026, Atea Pharmaceuticals, Inc. held its 2026 Annual Meeting of Stockhold...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/atea-shareholders-back-directors-auditors-and-executive-pay?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/atea-shareholders-back-directors-auditors-and-executive-pay?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVIR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645070787","title":"Atea Pharmaceuticals holds annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2645070787","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645070787?lang=en_us&edition=fundamental","pubTime":"2026-06-23 04:54","pubTimestamp":1782161668,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals held its annual shareholder meeting on June 18, 2026.Shareholders selected three directors for Class III board seats, with all nominees receiving sufficient support to take office.Shareholders backed an advisory vote on named executive officer pay.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atea Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 22, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDLTjv4k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AVIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638504510","title":"Atea says Phase 1 study shows omeprazole does not affect bemnifosbuvir-ruzasvir HCV regimen exposure","url":"https://stock-news.laohu8.com/highlight/detail?id=2638504510","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638504510?lang=en_us&edition=fundamental","pubTime":"2026-05-27 19:02","pubTimestamp":1779879775,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals disclosed Phase 1 data at EASL Congress 2026, with results already presented in conference posters.Studies indicated its bemnifosbuvir–ruzasvir hepatitis C regimen can be used with common medicines without meaningful interaction concerns.Findings supported co-administration with acid-reducing therapy and a widely used cholesterol drug without dose changes, reducing a key barrier to use.Separate preclinical results presented at EASL supported AT-587 as a potential hepatitis E treatment, with the company targeting a mid-year first-in-human study.The updates position the hepatitis C regimen for broader real-world use ahead of upcoming Phase 3 topline readouts.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDLbjZQ8W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVIR","IE00B64PRP62.GBP","IE00BN0W2W23.USD","BK4007","BK4112","NDAQ","LU2095319765.USD","LU0314104364.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","BK4585","SG9999014013.SGD","LU2210149790.SGD","BK4588","IE00BN0W2T93.GBP","IE00BKPKM429.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","IE00BGHQF748.EUR","SG9999014021.USD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638504107","title":"Atea Pharmaceuticals Inc - Phase 1 Study Shows Bem/Rzr Safe and Well-Tolerated With or Without Omeprazole","url":"https://stock-news.laohu8.com/highlight/detail?id=2638504107","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638504107?lang=en_us&edition=fundamental","pubTime":"2026-05-27 19:00","pubTimestamp":1779879603,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nTUA6XLNL2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AVIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638044665","title":"Atea Pharmaceuticals Inc - Omeprazole at 20 Mg Does Not Affect Bem/Rzr Plasma Exposure; 40 Mg Slightly Reduces Exposure","url":"https://stock-news.laohu8.com/highlight/detail?id=2638044665","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638044665?lang=en_us&edition=fundamental","pubTime":"2026-05-27 19:00","pubTimestamp":1779879603,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nTUA6XLNL2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVIR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638043675","title":"Atea Pharmaceuticals Presents New Drug-Drug Interaction Results Supporting Potential Best-in-Class Profile of the Regimen of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at Easl Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2638043675","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638043675?lang=en_us&edition=fundamental","pubTime":"2026-05-27 19:00","pubTimestamp":1779879603,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nTUA6XLNL2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVIR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637487821","title":"Atea director Polly Murphy buys 6,100 shares worth $25,446.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2637487821","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637487821?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:16","pubTimestamp":1779308185,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals director Polly A. Murphy bought 6,100 common shares at a weighted average price of 4.17 per share.Her direct holding rose to 92,145 shares following the purchase.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atea Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 20, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDL801xFZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Atea director Polly Murphy buys 6,100 shares worth $25,446.15","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AVIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636076388","title":"Atea Pharmaceuticals (AVIR) Receives a Hold from Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2636076388","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636076388?lang=en_us&edition=fundamental","pubTime":"2026-05-18 20:59","pubTimestamp":1779109185,"startTime":"0","endTime":"0","summary":"In a report released today, Maxwell Skor from Morgan Stanley maintained a Hold rating on Atea Pharmaceuticals, with a price target of $4.10. Accord...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/atea-pharmaceuticals-avir-receives-a-hold-from-morgan-stanley-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/atea-pharmaceuticals-avir-receives-a-hold-from-morgan-stanley-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1732799900.SGD","LU2111349929.HKD","LU1791710582.SGD","LU2487616109.SGD","LU0158827781.USD","LU1064131342.USD","LU1989772923.USD","LU0320765646.SGD","LU1244550221.USD","BK4127","LU0006306889.USD","LU0267386448.USD","LU1548497426.USD","LU0225283273.USD","LU1988902786.USD","LU2089283258.USD","LU0795875169.SGD","BK4007","IE00BKVL7J92.USD","LU0557290698.USD","LU1074936037.SGD","LU1363072403.SGD","LU1720051108.HKD","LU2347655156.SGD","LU2023251221.USD","LU0795875086.SGD","LU1732800096.USD","LU1720051017.SGD","BK4581","IE00BZ1G4Q59.USD","LU0528227936.USD","LU1244550494.USD","BK4516","LU2028103732.USD","LU2264538146.SGD","LU1791710400.SGD","LU1668664300.SGD","LU1989772840.SGD","LU0106261372.USD","BK4588","LU0390134368.USD","AVIR","LU0234570918.USD","LU0971096721.USD","LU2089284900.SGD","LU0106831901.USD","LU0158827948.USD","LU0882574139.USD","LU1244550577.SGD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635750513","title":"Atea Pharmaceuticals Sets Up Catalyst-Rich 2026 Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2635750513","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635750513?lang=en_us&edition=fundamental","pubTime":"2026-05-14 08:31","pubTimestamp":1778718680,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals, Inc. (($AVIR)) has held its Q1 earnings call. Read on for the main highlights of the call. Atea Pharmaceuticals’ latest earni...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/atea-pharmaceuticals-sets-up-catalyst-rich-2026-earnings-call?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/atea-pharmaceuticals-sets-up-catalyst-rich-2026-earnings-call?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635005780","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ibio (IBIO), MaxCyte (MXCT) and Atea Pharmaceuticals (AVIR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635005780","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635005780?lang=en_us&edition=fundamental","pubTime":"2026-05-13 21:30","pubTimestamp":1778679010,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Ibio (IBIO), MaxCyte (MXCT) and Atea Pharmaceutica...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-ibio-ibio-maxcyte-mxct-and-atea-pharmaceuticals-avir-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-ibio-ibio-maxcyte-mxct-and-atea-pharmaceuticals-avir-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU0128526141.USD","IBIO","BK4007","BK4121","LABU","AVIR","BK4539","XBI","BK4585","BK4588","HCSG","BK4568","LU0029874061.USD","MXCT","BK4139","BK4137","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635786986","title":"Atea presents new HCV trial data on bemnifosbuvir-ruzasvir at EASL 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2635786986","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635786986?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:04","pubTimestamp":1778670279,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals flagged new clinical and preclinical data across its viral hepatitis pipeline slated for presentation at EASL Congress 2026 in Barcelona on May 27-30.Two poster presentations will cover studies supporting its fixed-dose combination of bemnifosbuvir and ruzasvir for hepatitis C, including findings that suggest common acid-reducing therapy did not meaningfully change drug exposure and that the regimen shows limited potential for key drug-transport interactions.A top poster will present preclinical results for AT-587, a hepatitis E candidate positioned for first-in-class potential in a disease area with no approved therapies.The update comes ahead of expected topline Phase 3 readouts from C-BEYOND and C-FORWARD, which remain central to the hepatitis C program’s commercial outlook.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated cont","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL9gcB3f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVIR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635607786","title":"Atea Pharmaceuticals to Present Three Abstracts at EASL 2026 Congress Highlighting Progress Across Viral Hepatitis Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2635607786","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635607786?lang=en_us&edition=fundamental","pubTime":"2026-05-13 19:00","pubTimestamp":1778670000,"startTime":"0","endTime":"0","summary":"BOSTON, May  13, 2026  (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of oral","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/13/3293835/0/en/Atea-Pharmaceuticals-to-Present-Three-Abstracts-at-EASL-2026-Congress-Highlighting-Progress-Across-Viral-Hepatitis-Pipeline.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVIR","BK4007","PRGS","LU2065732104.USD","SOF","BK4097","CET"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635223539","title":"BRIEF-Atea Pharmaceuticals Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2635223539","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635223539?lang=en_us&edition=fundamental","pubTime":"2026-05-13 05:04","pubTimestamp":1778619870,"startTime":"0","endTime":"0","summary":"BRIEF-Atea Pharmaceuticals Reports First Quarter 2026 Financial Results May 12 (Reuters) - Atea Pharmaceuticals Inc AVIR.O:ATEA PHARMACEUTICALS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS AND PROVIDE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUA9VCZ4B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AVIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635522380","title":"Atea Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635522380","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635522380?lang=en_us&edition=fundamental","pubTime":"2026-05-13 05:02","pubTimestamp":1778619739,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings SummaryAtea Pharmaceuticals Inc AVIR.OQ reported a quarterly adjusted loss of 57 cents per share for the quarter ende","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL8N41P37Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AVIR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635024043","title":"Atea Pharmaceuticals Q1 net loss widens on higher R&D spending","url":"https://stock-news.laohu8.com/highlight/detail?id=2635024043","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635024043?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:27","pubTimestamp":1778617620,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals Q1 net loss widens on higher R&D spendingOverviewU.S. antiviral drug developer's Q1 net loss widened on higher R&D spending for HCV and HEV programsCompany ended Q1 with $256 mln ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL1N41P1F9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVIR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":59,"code":"91000000","status":"200"}]}}